苦参碱在肝细胞癌中作用机制的研究进展.pdf
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 苦参 肝细胞 作用 机制 研究进展
- 资源描述:
-
2000
王显文,等苦参碱在肝细胞癌中作用机制的研究进展
noma J. Mol Caneer, 2010. 9: 16
gene and hepatocellular earcinoma development: a meta-analysis
25 Li L, Zhang L, Zhang Y, et al. Inereased expression of LNCRNA
J」. Genel Miol Res,2015,14(2):6762-6772
BANCR is associated with elinical progression and poor prognosis _35 Zhou T, Gao Y Inereased expression of LNCRNA BANCR and its
in gastric cancer[ J]. Biomed Pharmacother, 2015,72: 109-112
prognostic significance in human hepatocellular carcinoma [J I
26 Chen AY, Jemal A, Ward EM. Increasing incidence of differentia
World J Surg Oncol. 2016, 14(1): 8
ted thyroid cancer in the United States, 1988-2005 J. Cancer. 36 Wang HL, hang J P, Li DY, et al. Clinical significance of BANCR
2009.115(16):3801-3817
in hepatocellular carcinoma[ J]. World Chin J Diges
Davies L, Welch HG. Current thvroid cancer trends in the United
tol,2016,24(2):19%-202.[王浩联,张金平,李东颖,等
States J]. JAMA Otolaryngol Iead Neck Surg, 2014, 140(4)
BANC.R在肝细胞肝將中的表达及其临床意义[J].世界华人
317-322
消化杂志,2016,24(2):196-202
28 Tang KT, Lee CH. BRAF mutation in papillary thyroid carcinoma
37 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 J. CA
pathogenic role and clinical implications J.J Chin Med Assoc
Cancer Clin,2016,66(1):7-30.
2010,73(3):113-128
38 Racioppi M, Agostino D, Totaro 4, et al. Value of current chemo
29 Wang Y Guo Q Zhao Y,et al. Braf-activated long non-cod
therapy and surgery in advanced and metastatic bladder cancer
ing RNA contributes to cell proliferation and activates autophagy
J]. Urol Int,2012,88:249-258
in papillary thyroid carcinoma J. Oncol Lell, 2014, 8(5): 1947
39 Rosetl, Milowsky MI Improving systemic chemotherapy for blad
-1952
der cancer_JI.Curr Oncol Rep, 2016, 18: 27
30 Khan MS, Pandith AA, Masnndi SR, et al. Epigenetic silencing of 40 Zhan Y, Iiu Y, Wang et al. Increased expression of sumo p3
TSHR sene in thyroid cancer patients in relation to Lheir BRAF
predicts poor prognosis and promotes turnor growth and metastasis
V600E mutation status.Endoerine, 2014, 47(2): 449-455
in bladder cancer]. Oncotarget 2016.7(13): 16038-16048
as a lumor suppressor in papillary thyroid cancer. J]. Oneatangeul, [41] Zhan Y, Lin J. Iiu Y, ct al. Up-regulation of long non-coding
31 Liao T Qu N Shi RL, ct al. Braf-activated INCRNA functions
rna pandar is associated with poor prognosis and promotes Lumori-
2016(Advance Publication)
genesis in bladder cancer_ JIJ Exp Clin Cancer Res, 2016, 35
32 Parkin DM. Clobal cancer statistics. 2002IJ] CA Cancer J Clini
clans,2005,55(2):74-108
42 He A Over-expression of long noncoding RNA BANCR inhibits
33cartularo L Gene expression and pathway analysis of human hepa
malignant phenotypes of human bladder cancer [J. J Exp Clin
tocellular carcinoma cells treated with cadmium J]. Toxicol Appl
Cancer Res,2016,35(1):125
Pharmacol.2015.288(3):399-408
(编校:刘跳英)
34 Ii QF. Correlation between promoter methylation in the GSTPT
苦参碔在肝细胞癌中作用机制的研究进展
王昱文,成秉林,张淑君2
Research progress of mechanism of matrine in hepatocellular carcinom
Wang Yuwen, Cheng Binglin, Zhang Shujun
Department of Intergrated Traditional Chinese and Western Medical ncology, the First Afiliated Hospital of larbin Medical University
Heilongiang Harbin 150000, hn e men of展开阅读全文
文档分享网所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。



链接地址:https://www.wdfxw.net/doc97528063.htm